re: next acquisition I also believe this is possible since i am Mayne shareholder and at their yearly presentation i read that they are on prowl for oncology company . Also Sirtex has partnership with Mayne products of Oxaliplatin and Irinotecan which are in late trials as working very well with Sirtex Sir spheres in metastatic cancer to the liver. Sirtex shares look very undervalued I agree Also Oxaliplatin and Irinotecan with Sirtex Sir Sphers are billion dollar sales potential.
- Forums
- ASX - By Stock
- allows cytyc corp due dilligence
re: next acquisition I also believe this is possible since i am...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.72 |
Change
0.310(4.18%) |
Mkt cap ! $965.8M |
Open | High | Low | Value | Volume |
$7.47 | $7.72 | $7.45 | $897.0K | 118.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 228 | $7.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.80 | 5629 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
VSL (ASX) Chart |